//php print_r(get_the_ID()); ?>
Context:
The Medicines Patent Pool (MPP) has signed sub licence agreements with the India based companies Eugia, Hetero and Dr. Reddy’s Laboratories, along with the Indonesian firm BrightGene, to make generic versions of the drug Nilotinib.
What is Nilotinib?
About Medicines Patent Pool:
News Source: The Hindu
To get PDF version, Please click on "Print PDF" button.
What National Sports Policy can do for India’s A...
Ukraine-Russia: A War turned into a Costly Test of...
China, India and the Conflict over Buddhism
At FTA’s Heart, the Promise of Global Capacity C...
Student Suicides in Universities are often a Produ...
Milk that has its Source in Soil: The Growing Popu...
<div class="new-fform">
</div>